ReviewPublished 7 October 2026The role of personalised medicine in treating high-risk neuroblastoma in paediatric patientsDaniele Ammeti · Debora Curci · Martina Franzin · Marco Rabusin · Melania Eva Zanchetta · Antonella FabrettoOncology Reviewsdoi 10.3389/or.2026.1850627
Original ResearchPublished 2 October 2026Longitudinal single-cell analysis identifies a chemotherapy-suppressed proliferative program associated with adverse prognosis in neuroblastomaAiguo Zhu · Jian WangFrontiers in Geneticsdoi 10.3389/fgene.2026.1878093
Original ResearchPublished 28 September 2026Divergent cellular responses to sciatic nerve crush versus transection: bilateral MYCN induction and distinct DRG neuronal responsesShilian Zhou · Ziyan Huang · Zhongyuan Lin · Jingwei Chen · Xinyu Zhang · Diya Wang · Haihua Shu · Fang YeFrontiers in Cellular Neurosciencedoi 10.3389/fncel.2026.1922426
Original ResearchPublished 26 August 2026Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept studyMaham Ansari · Abdul Wali · Mohhamed Rasul · Kristina Gemzell Danielsson · Twana Alkasalias · Muhammad MushtaqFrontiers in Agingdoi 10.3389/fragi.2026.1783019